Chiesi, $1.9 billion deal to acquire KalVista - Il Sole 24 ORE
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
Track acquisitions, mergers, and investments in the healthcare sector.
Tentt has tracked 666 healthcare M&A deals, with 225 transactions recorded in the last 30 days. The most active sub-sectors include Healthcare Services Other (163), Pharmacy (135), Medical Devices (106), Healthcare It (40).
California leads with 55 deals, followed by New York and Florida. Strategic accounts for 68% of buyer activity in this sector, with Private Equity (145), Public Company (27) also active.
The most recent transaction tracked is "Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18."
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
Teva→Emalex Biosciences
Apr 29, 2026
Teva→Emalex Biosciences
Apr 29, 2026
Chiesi→KalVista Pharmaceuticals
Apr 29, 2026
CareDx→Naveris
Apr 29, 2026
Sun Pharmaceutical Industries→Organon
Apr 29, 2026
CareDx→Naveris
Apr 29, 2026
Teva→Emalex Biosciences
Apr 29, 2026
Chiesi Farmaceutici→KalVista Pharmaceuticals
Apr 29, 2026
UConn Health→Day Kimball Hospital and Bristol Health
Apr 28, 2026
Asante→Surgery Center of Southern Oregon
Apr 28, 2026
CareDx→Naveris
Apr 28, 2026
Eli Lilly→Ajax Therapeutics
Apr 28, 2026
IKS Health→TruBridge
Apr 28, 2026
Sun Pharmaceutical Industries→Organon
Apr 28, 2026
Astorg→Thermo Fisher microbiology business
Apr 28, 2026
Gilead Sciences→Arcellx
Apr 28, 2026
Gilead Sciences→Arcellx
Apr 28, 2026
Superior Health Holdings→Chant Healthcare
Apr 28, 2026
Neurocrine Biosciences→Soleno Therapeutics
Apr 28, 2026